Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 22(22)2021 Nov 22.
Artigo em Inglês | MEDLINE | ID: mdl-34830469

RESUMO

Leishmaniasis is a neglected tropical disease caused by Leishmania spp. The improvement of existing treatments and the discovery of new drugs remain ones of the major goals in control and eradication of this disease. From the parasite genome, we have identified the homologue of the human oncogene PES1 in Leishmania major (LmjPES). It has been demonstrated that PES1 is involved in several processes such as ribosome biogenesis, cell proliferation and genetic transcription. Our phylogenetic studies showed that LmjPES encodes a highly conserved protein containing three main domains: PES N-terminus (shared with proteins involved in ribosomal biogenesis), BRCT (found in proteins related to DNA repair processes) and MAEBL-type domain (C-terminus, related to erythrocyte invasion in apicomplexan). This gene showed its highest expression level in metacyclic promastigotes, the infective forms; by fluorescence microscopy assay, we demonstrated the nuclear localization of LmjPES protein. After generating mutant parasites overexpressing LmjPES, we observed that these clones displayed a dramatic increase in the ratio of cell infection within macrophages. Furthermore, BALB/c mice infected with these transgenic parasites exhibited higher footpad inflammation compared to those inoculated with non-overexpressing parasites.


Assuntos
Leishmania major/genética , Leishmaniose/genética , Doenças Parasitárias/genética , Proteínas/genética , Animais , Sequência Conservada/genética , Humanos , Leishmania major/patogenicidade , Leishmaniose/parasitologia , Macrófagos/metabolismo , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Doenças Parasitárias/parasitologia , Proteínas de Ligação a RNA/genética
2.
Cell Physiol Biochem ; 36(4): 1499-516, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26159107

RESUMO

BACKGROUND/AIMS: Tumor necrosis factor-α (TNF-α)-mediated chronic low-grade inflammation of adipose tissue is associated with obesity and insulin resistance. Caveolin-1 (Cav-1) is the central component of adipocyte caveolae and has an essential role in the regulation of insulin signaling. The effects of TNF-α on Cav-1 expression and insulin signaling during adipocyte differentiation and in mature adipocytes were studied. METHODS: 3T3-L1 cells were differentiated (21 days) in the presence TNF-α (10 ng/mL) and mature adipocytes were also treated with TNF-α for 48 hours. Cav-1 and insulin receptor (IR) gene methylation were determined as well as Cav-1, IR, PKB/AKT-2 and Glut-4 expression and activation by real time RT-PCR and western blot. Baseline and insulin-induced glucose uptake was measured by the 2-[C14]-deoxyglucose uptake assay. RESULTS: TNF-α slowed down the differentiation program, hindering the expression of some insulin signaling intermediates without fully eliminating insulin-mediated glucose uptake. In mature adipocytes, TNF-α did not compromise lipid-storage capacity, but downregulated the expression of the insulin signaling intermediates, totally blocking insulin-mediated glucose uptake. Insulin sensitivity correlated with the level of activated phospho-Cav-1 in both situations, strongly suggesting the direct contribution of Cav-1 to the maintenance of this physiological response. CONCLUSION: Cav-1 activation by phosphorylation seems to be essential for the maintenance of an active and insulin-sensitive glucose uptake.


Assuntos
Adipócitos/citologia , Adipogenia , Caveolina 1/genética , Insulina/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Células 3T3-L1 , Adipócitos/metabolismo , Adipocinas/metabolismo , Animais , Caveolina 1/metabolismo , Sobrevivência Celular , Metilação de DNA , Regulação da Expressão Gênica , Glucose/metabolismo , Resistência à Insulina , Metabolismo dos Lipídeos , Camundongos , Fosforilação , Transdução de Sinais
3.
Biomolecules ; 9(11)2019 11 11.
Artigo em Inglês | MEDLINE | ID: mdl-31718000

RESUMO

The identification and clarification of the mechanisms of action of drugs used against leishmaniasis may improve their administration regimens and prevent the development of resistant strains. Herein, for the first time, we describe the structure of the putatively essential Ser/Thr kinase LmjF.22.0810 from Leishmania major. Molecular dynamics simulations were performed to assess the stability of the kinase model. The analysis of its sequence and structure revealed two druggable sites on the protein. Furthermore, in silico docking of small molecules showed that aminoglycosides preferentially bind to the phosphorylation site of the protein. Given that transgenic LmjF.22.0810-overexpressing parasites displayed less sensitivity to aminoglycosides such as paromomycin, our predicted models support the idea that the mechanism of drug resistance observed in those transgenic parasites is the tight binding of such compounds to LmjF.22.0810 associated with its overexpression. These results may be helpful to understand the complex machinery of drug response in Leishmania.


Assuntos
Leishmania major/efeitos dos fármacos , Leishmaniose Cutânea/tratamento farmacológico , Paromomicina/efeitos adversos , Proteínas Serina-Treonina Quinases/genética , Antiprotozoários , Resistência a Medicamentos/genética , Humanos , Leishmania major/enzimologia , Leishmania major/patogenicidade , Leishmaniose Cutânea/genética , Leishmaniose Cutânea/parasitologia , Simulação de Dinâmica Molecular , Paromomicina/química , Proteínas Serina-Treonina Quinases/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA